 | • レポートコード：MRC2-11QY02709 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はアスペルギルス症薬のグローバル市場について調査・分析したレポートです。種類別（カスポファンギンアセテート、イトラコナゾールカプセル、ボリコナゾール錠）市場規模、用途別（侵襲性アスペルギルス症、アレルギー性アスペルギルス症、アレルギー性気管支肺アスペルギルス症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アスペルギルス症薬の競争状況、市場シェア ・世界のアスペルギルス症薬市場：種類別市場規模 2015年-2020年（カスポファンギンアセテート、イトラコナゾールカプセル、ボリコナゾール錠） ・世界のアスペルギルス症薬市場：種類別市場規模予測 2021年-2026年（カスポファンギンアセテート、イトラコナゾールカプセル、ボリコナゾール錠） ・世界のアスペルギルス症薬市場：用途別市場規模 2015年-2020年（侵襲性アスペルギルス症、アレルギー性アスペルギルス症、アレルギー性気管支肺アスペルギルス症） ・世界のアスペルギルス症薬市場：用途別市場規模予測 2021年-2026年（侵襲性アスペルギルス症、アレルギー性アスペルギルス症、アレルギー性気管支肺アスペルギルス症） ・北米のアスペルギルス症薬市場分析：米国、カナダ ・ヨーロッパのアスペルギルス症薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアスペルギルス症薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアスペルギルス症薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアスペルギルス症薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Pfizer Deutschland GmbH、GSK、Janssen Pharmaceutica、Astellas、Basilea Pharmaceutica、Cardinal Health、Taj Pharma、SRS Pharmaceuticals Pvt. Ltd、United Biotech、Lepu Pharmaceuticals、Tianjin Lisheng Pharmaceutical、Honz Pharmaceutical、Huasun Pharmaceutical、Luoxin Biotechnology、Natco Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Aspergillosis Drugs Market
The global Aspergillosis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Aspergillosis Drugs Scope and Market Size
Aspergillosis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aspergillosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Aspergillosis Drugs market is segmented into
Caspofungin Acetate
Itraconazole Capsules
Voriconazole Tablets
Segment by Application, the Aspergillosis Drugs market is segmented into
Invasive Aspergillosis
Allergic Aspergillosis
Allergic Bronchopulmonary Aspergillosis
Regional and Country-level Analysis
The Aspergillosis Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Aspergillosis Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Aspergillosis Drugs Market Share Analysis
Aspergillosis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Aspergillosis Drugs business, the date to enter into the Aspergillosis Drugs market, Aspergillosis Drugs product introduction, recent developments, etc.
The major vendors covered:
Merck
Pfizer Deutschland GmbH
GSK
Janssen Pharmaceutica
Astellas
Basilea Pharmaceutica
Cardinal Health
Taj Pharma
SRS Pharmaceuticals Pvt. Ltd
United Biotech
Lepu Pharmaceuticals
Tianjin Lisheng Pharmaceutical
Honz Pharmaceutical
Huasun Pharmaceutical
Luoxin Biotechnology
Natco Pharma
1 Study Coverage
1.1 Aspergillosis Drugs Product Introduction
1.2 Market Segments
1.3 Key Aspergillosis Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Aspergillosis Drugs Market Size Growth Rate by Type
1.4.2 Caspofungin Acetate
1.4.3 Itraconazole Capsules
1.4.4 Voriconazole Tablets
1.5 Market by Application
1.5.1 Global Aspergillosis Drugs Market Size Growth Rate by Application
1.5.2 Invasive Aspergillosis
1.5.3 Allergic Aspergillosis
1.5.4 Allergic Bronchopulmonary Aspergillosis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Aspergillosis Drugs Market Size, Estimates and Forecasts
2.1.1 Global Aspergillosis Drugs Revenue 2015-2026
2.1.2 Global Aspergillosis Drugs Sales 2015-2026
2.2 Global Aspergillosis Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Aspergillosis Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Aspergillosis Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Aspergillosis Drugs Competitor Landscape by Players
3.1 Aspergillosis Drugs Sales by Manufacturers
3.1.1 Aspergillosis Drugs Sales by Manufacturers (2015-2020)
3.1.2 Aspergillosis Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Aspergillosis Drugs Revenue by Manufacturers
3.2.1 Aspergillosis Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Aspergillosis Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Aspergillosis Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Aspergillosis Drugs Revenue in 2019
3.2.5 Global Aspergillosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Aspergillosis Drugs Price by Manufacturers
3.4 Aspergillosis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Aspergillosis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Aspergillosis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Aspergillosis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Aspergillosis Drugs Market Size by Type (2015-2020)
4.1.1 Global Aspergillosis Drugs Sales by Type (2015-2020)
4.1.2 Global Aspergillosis Drugs Revenue by Type (2015-2020)
4.1.3 Aspergillosis Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Aspergillosis Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Aspergillosis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Aspergillosis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Aspergillosis Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Aspergillosis Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Aspergillosis Drugs Market Size by Application (2015-2020)
5.1.1 Global Aspergillosis Drugs Sales by Application (2015-2020)
5.1.2 Global Aspergillosis Drugs Revenue by Application (2015-2020)
5.1.3 Aspergillosis Drugs Price by Application (2015-2020)
5.2 Aspergillosis Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Aspergillosis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Aspergillosis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Aspergillosis Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Aspergillosis Drugs by Country
6.1.1 North America Aspergillosis Drugs Sales by Country
6.1.2 North America Aspergillosis Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Aspergillosis Drugs Market Facts & Figures by Type
6.3 North America Aspergillosis Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Aspergillosis Drugs by Country
7.1.1 Europe Aspergillosis Drugs Sales by Country
7.1.2 Europe Aspergillosis Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Aspergillosis Drugs Market Facts & Figures by Type
7.3 Europe Aspergillosis Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Aspergillosis Drugs by Region
8.1.1 Asia Pacific Aspergillosis Drugs Sales by Region
8.1.2 Asia Pacific Aspergillosis Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Aspergillosis Drugs Market Facts & Figures by Type
8.3 Asia Pacific Aspergillosis Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Aspergillosis Drugs by Country
9.1.1 Latin America Aspergillosis Drugs Sales by Country
9.1.2 Latin America Aspergillosis Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Aspergillosis Drugs Market Facts & Figures by Type
9.3 Central & South America Aspergillosis Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Aspergillosis Drugs by Country
10.1.1 Middle East and Africa Aspergillosis Drugs Sales by Country
10.1.2 Middle East and Africa Aspergillosis Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Aspergillosis Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Aspergillosis Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Aspergillosis Drugs Products Offered
11.1.5 Merck Related Developments
11.2 Pfizer Deutschland GmbH
11.2.1 Pfizer Deutschland GmbH Corporation Information
11.2.2 Pfizer Deutschland GmbH Description and Business Overview
11.2.3 Pfizer Deutschland GmbH Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Deutschland GmbH Aspergillosis Drugs Products Offered
11.2.5 Pfizer Deutschland GmbH Related Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Description and Business Overview
11.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GSK Aspergillosis Drugs Products Offered
11.3.5 GSK Related Developments
11.4 Janssen Pharmaceutica
11.4.1 Janssen Pharmaceutica Corporation Information
11.4.2 Janssen Pharmaceutica Description and Business Overview
11.4.3 Janssen Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Janssen Pharmaceutica Aspergillosis Drugs Products Offered
11.4.5 Janssen Pharmaceutica Related Developments
11.5 Astellas
11.5.1 Astellas Corporation Information
11.5.2 Astellas Description and Business Overview
11.5.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Astellas Aspergillosis Drugs Products Offered
11.5.5 Astellas Related Developments
11.6 Basilea Pharmaceutica
11.6.1 Basilea Pharmaceutica Corporation Information
11.6.2 Basilea Pharmaceutica Description and Business Overview
11.6.3 Basilea Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Basilea Pharmaceutica Aspergillosis Drugs Products Offered
11.6.5 Basilea Pharmaceutica Related Developments
11.7 Cardinal Health
11.7.1 Cardinal Health Corporation Information
11.7.2 Cardinal Health Description and Business Overview
11.7.3 Cardinal Health Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Cardinal Health Aspergillosis Drugs Products Offered
11.7.5 Cardinal Health Related Developments
11.8 Taj Pharma
11.8.1 Taj Pharma Corporation Information
11.8.2 Taj Pharma Description and Business Overview
11.8.3 Taj Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Taj Pharma Aspergillosis Drugs Products Offered
11.8.5 Taj Pharma Related Developments
11.9 SRS Pharmaceuticals Pvt. Ltd
11.9.1 SRS Pharmaceuticals Pvt. Ltd Corporation Information
11.9.2 SRS Pharmaceuticals Pvt. Ltd Description and Business Overview
11.9.3 SRS Pharmaceuticals Pvt. Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 SRS Pharmaceuticals Pvt. Ltd Aspergillosis Drugs Products Offered
11.9.5 SRS Pharmaceuticals Pvt. Ltd Related Developments
11.10 United Biotech
11.10.1 United Biotech Corporation Information
11.10.2 United Biotech Description and Business Overview
11.10.3 United Biotech Sales, Revenue and Gross Margin (2015-2020)
11.10.4 United Biotech Aspergillosis Drugs Products Offered
11.10.5 United Biotech Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Aspergillosis Drugs Products Offered
11.1.5 Merck Related Developments
11.12 Tianjin Lisheng Pharmaceutical
11.12.1 Tianjin Lisheng Pharmaceutical Corporation Information
11.12.2 Tianjin Lisheng Pharmaceutical Description and Business Overview
11.12.3 Tianjin Lisheng Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Tianjin Lisheng Pharmaceutical Products Offered
11.12.5 Tianjin Lisheng Pharmaceutical Related Developments
11.13 Honz Pharmaceutical
11.13.1 Honz Pharmaceutical Corporation Information
11.13.2 Honz Pharmaceutical Description and Business Overview
11.13.3 Honz Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Honz Pharmaceutical Products Offered
11.13.5 Honz Pharmaceutical Related Developments
11.14 Huasun Pharmaceutical
11.14.1 Huasun Pharmaceutical Corporation Information
11.14.2 Huasun Pharmaceutical Description and Business Overview
11.14.3 Huasun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Huasun Pharmaceutical Products Offered
11.14.5 Huasun Pharmaceutical Related Developments
11.15 Luoxin Biotechnology
11.15.1 Luoxin Biotechnology Corporation Information
11.15.2 Luoxin Biotechnology Description and Business Overview
11.15.3 Luoxin Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Luoxin Biotechnology Products Offered
11.15.5 Luoxin Biotechnology Related Developments
11.16 Natco Pharma
11.16.1 Natco Pharma Corporation Information
11.16.2 Natco Pharma Description and Business Overview
11.16.3 Natco Pharma Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Natco Pharma Products Offered
11.16.5 Natco Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Aspergillosis Drugs Market Estimates and Projections by Region
12.1.1 Global Aspergillosis Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Aspergillosis Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Aspergillosis Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Aspergillosis Drugs Sales Forecast (2021-2026)
12.2.2 North America: Aspergillosis Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Aspergillosis Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Aspergillosis Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Aspergillosis Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Aspergillosis Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Aspergillosis Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Aspergillosis Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Aspergillosis Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Aspergillosis Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Aspergillosis Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Aspergillosis Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Aspergillosis Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Aspergillosis Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Aspergillosis Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Aspergillosis Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Aspergillosis Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Aspergillosis Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Aspergillosis Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Aspergillosis Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Aspergillosis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Aspergillosis Drugs Market Segments
Table 2. Ranking of Global Top Aspergillosis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Aspergillosis Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Caspofungin Acetate
Table 5. Major Manufacturers of Itraconazole Capsules
Table 6. Major Manufacturers of Voriconazole Tablets
Table 7. Global Aspergillosis Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Aspergillosis Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Aspergillosis Drugs Sales by Regions 2015-2020 (K MT)
Table 10. Global Aspergillosis Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Aspergillosis Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Aspergillosis Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Aspergillosis Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Aspergillosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Aspergillosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aspergillosis Drugs as of 2019)
Table 16. Aspergillosis Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Aspergillosis Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Aspergillosis Drugs Price (2015-2020) (USD/MT)
Table 19. Aspergillosis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Aspergillosis Drugs Product Type
Table 21. Date of International Manufacturers Enter into Aspergillosis Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Aspergillosis Drugs Sales by Type (2015-2020) (K MT)
Table 24. Global Aspergillosis Drugs Sales Share by Type (2015-2020)
Table 25. Global Aspergillosis Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Aspergillosis Drugs Revenue Share by Type (2015-2020)
Table 27. Aspergillosis Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Aspergillosis Drugs Sales by Application (2015-2020) (K MT)
Table 29. Global Aspergillosis Drugs Sales Share by Application (2015-2020)
Table 30. North America Aspergillosis Drugs Sales by Country (2015-2020) (K MT)
Table 31. North America Aspergillosis Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Aspergillosis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Aspergillosis Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Aspergillosis Drugs Sales by Type (2015-2020) (K MT)
Table 35. North America Aspergillosis Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Aspergillosis Drugs Sales by Application (2015-2020) (K MT)
Table 37. North America Aspergillosis Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Aspergillosis Drugs Sales by Country (2015-2020) (K MT)
Table 39. Europe Aspergillosis Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Aspergillosis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Aspergillosis Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Aspergillosis Drugs Sales by Type (2015-2020) (K MT)
Table 43. Europe Aspergillosis Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Aspergillosis Drugs Sales by Application (2015-2020) (K MT)
Table 45. Europe Aspergillosis Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Aspergillosis Drugs Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Aspergillosis Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Aspergillosis Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Aspergillosis Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Aspergillosis Drugs Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Aspergillosis Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Aspergillosis Drugs Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Aspergillosis Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Aspergillosis Drugs Sales by Country (2015-2020) (K MT)
Table 55. Latin America Aspergillosis Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Aspergillosis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Aspergillosis Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Aspergillosis Drugs Sales by Type (2015-2020) (K MT)
Table 59. Latin America Aspergillosis Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Aspergillosis Drugs Sales by Application (2015-2020) (K MT)
Table 61. Latin America Aspergillosis Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Aspergillosis Drugs Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Aspergillosis Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Aspergillosis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Aspergillosis Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Aspergillosis Drugs Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Aspergillosis Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Aspergillosis Drugs Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Aspergillosis Drugs Sales Market Share by Application (2015-2020)
Table 70. Merck Corporation Information
Table 71. Merck Description and Major Businesses
Table 72. Merck Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Merck Product
Table 74. Merck Recent Development
Table 75. Pfizer Deutschland GmbH Corporation Information
Table 76. Pfizer Deutschland GmbH Description and Major Businesses
Table 77. Pfizer Deutschland GmbH Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Deutschland GmbH Product
Table 79. Pfizer Deutschland GmbH Recent Development
Table 80. GSK Corporation Information
Table 81. GSK Description and Major Businesses
Table 82. GSK Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GSK Product
Table 84. GSK Recent Development
Table 85. Janssen Pharmaceutica Corporation Information
Table 86. Janssen Pharmaceutica Description and Major Businesses
Table 87. Janssen Pharmaceutica Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Janssen Pharmaceutica Product
Table 89. Janssen Pharmaceutica Recent Development
Table 90. Astellas Corporation Information
Table 91. Astellas Description and Major Businesses
Table 92. Astellas Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Astellas Product
Table 94. Astellas Recent Development
Table 95. Basilea Pharmaceutica Corporation Information
Table 96. Basilea Pharmaceutica Description and Major Businesses
Table 97. Basilea Pharmaceutica Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Basilea Pharmaceutica Product
Table 99. Basilea Pharmaceutica Recent Development
Table 100. Cardinal Health Corporation Information
Table 101. Cardinal Health Description and Major Businesses
Table 102. Cardinal Health Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Cardinal Health Product
Table 104. Cardinal Health Recent Development
Table 105. Taj Pharma Corporation Information
Table 106. Taj Pharma Description and Major Businesses
Table 107. Taj Pharma Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Taj Pharma Product
Table 109. Taj Pharma Recent Development
Table 110. SRS Pharmaceuticals Pvt. Ltd Corporation Information
Table 111. SRS Pharmaceuticals Pvt. Ltd Description and Major Businesses
Table 112. SRS Pharmaceuticals Pvt. Ltd Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. SRS Pharmaceuticals Pvt. Ltd Product
Table 114. SRS Pharmaceuticals Pvt. Ltd Recent Development
Table 115. United Biotech Corporation Information
Table 116. United Biotech Description and Major Businesses
Table 117. United Biotech Aspergillosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. United Biotech Product
Table 119. United Biotech Recent Development
Table 120. Lepu Pharmaceuticals Corporation Information
Table 121. Lepu Pharmaceuticals Description and Major Businesses
Table 122. Lepu Pharmaceuticals Aspergillosis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Lepu Pharmaceuticals Product
Table 124. Lepu Pharmaceuticals Recent Development
Table 125. Tianjin Lisheng Pharmaceutical Corporation Information
Table 126. Tianjin Lisheng Pharmaceutical Description and Major Businesses
Table 127. Tianjin Lisheng Pharmaceutical Aspergillosis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Tianjin Lisheng Pharmaceutical Product
Table 129. Tianjin Lisheng Pharmaceutical Recent Development
Table 130. Honz Pharmaceutical Corporation Information
Table 131. Honz Pharmaceutical Description and Major Businesses
Table 132. Honz Pharmaceutical Aspergillosis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Honz Pharmaceutical Product
Table 134. Honz Pharmaceutical Recent Development
Table 135. Huasun Pharmaceutical Corporation Information
Table 136. Huasun Pharmaceutical Description and Major Businesses
Table 137. Huasun Pharmaceutical Aspergillosis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Huasun Pharmaceutical Product
Table 139. Huasun Pharmaceutical Recent Development
Table 140. Luoxin Biotechnology Corporation Information
Table 141. Luoxin Biotechnology Description and Major Businesses
Table 142. Luoxin Biotechnology Aspergillosis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Luoxin Biotechnology Product
Table 144. Luoxin Biotechnology Recent Development
Table 145. Natco Pharma Corporation Information
Table 146. Natco Pharma Description and Major Businesses
Table 147. Natco Pharma Aspergillosis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Natco Pharma Product
Table 149. Natco Pharma Recent Development
Table 150. Global Aspergillosis Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 151. Global Aspergillosis Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 152. Global Aspergillosis Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 153. Global Aspergillosis Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 154. North America: Aspergillosis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 155. North America: Aspergillosis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Europe: Aspergillosis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 157. Europe: Aspergillosis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Asia Pacific: Aspergillosis Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 159. Asia Pacific: Aspergillosis Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 160. Latin America: Aspergillosis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 161. Latin America: Aspergillosis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Middle East and Africa: Aspergillosis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 163. Middle East and Africa: Aspergillosis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 165. Key Challenges
Table 166. Market Risks
Table 167. Main Points Interviewed from Key Aspergillosis Drugs Players
Table 168. Aspergillosis Drugs Customers List
Table 169. Aspergillosis Drugs Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Aspergillosis Drugs Product Picture
Figure 2. Global Aspergillosis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Caspofungin Acetate Product Picture
Figure 4. Itraconazole Capsules Product Picture
Figure 5. Voriconazole Tablets Product Picture
Figure 6. Global Aspergillosis Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Invasive Aspergillosis
Figure 8. Allergic Aspergillosis
Figure 9. Allergic Bronchopulmonary Aspergillosis
Figure 10. Aspergillosis Drugs Report Years Considered
Figure 11. Global Aspergillosis Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Aspergillosis Drugs Sales 2015-2026 (K MT)
Figure 13. Global Aspergillosis Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Aspergillosis Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Aspergillosis Drugs Sales Market Share by Region in 2019
Figure 16. Global Aspergillosis Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Aspergillosis Drugs Revenue Market Share by Region in 2019
Figure 18. Global Aspergillosis Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Aspergillosis Drugs Revenue in 2019
Figure 20. Aspergillosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Aspergillosis Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Aspergillosis Drugs Sales Market Share by Type in 2019
Figure 23. Global Aspergillosis Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Aspergillosis Drugs Revenue Market Share by Type in 2019
Figure 25. Global Aspergillosis Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Aspergillosis Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Aspergillosis Drugs Sales Market Share by Application in 2019
Figure 28. Global Aspergillosis Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Aspergillosis Drugs Revenue Market Share by Application in 2019
Figure 30. North America Aspergillosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Aspergillosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Aspergillosis Drugs Sales Market Share by Country in 2019
Figure 33. North America Aspergillosis Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Aspergillosis Drugs Market Share by Type in 2019
Figure 39. North America Aspergillosis Drugs Market Share by Application in 2019
Figure 40. Europe Aspergillosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Aspergillosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Aspergillosis Drugs Sales Market Share by Country in 2019
Figure 43. Europe Aspergillosis Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Aspergillosis Drugs Market Share by Type in 2019
Figure 55. Europe Aspergillosis Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Aspergillosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Aspergillosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Aspergillosis Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Aspergillosis Drugs Revenue Market Share by Region in 2019
Figure 60. China Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Aspergillosis Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Aspergillosis Drugs Market Share by Application in 2019
Figure 84. Latin America Aspergillosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Aspergillosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Aspergillosis Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Aspergillosis Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Aspergillosis Drugs Market Share by Type in 2019
Figure 95. Latin America Aspergillosis Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Aspergillosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Aspergillosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Aspergillosis Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Aspergillosis Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Aspergillosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Aspergillosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Aspergillosis Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Aspergillosis Drugs Market Share by Application in 2019
Figure 108. North America Aspergillosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Aspergillosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Aspergillosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Aspergillosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Aspergillosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Aspergillosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Aspergillosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Aspergillosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Aspergillosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Aspergillosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…- 喘息薬の世界市場（～2026年） Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell …
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- アレルギー性結膜炎の世界市場（～2026年） Allergic conjunctivitis is an eye inflammation caused by an allergic reaction to substances like pollen or mold spores. There are different types of allergic conjunctivitis such as seasonal allergic conjunctivitis, perennial allergic conjunctivitis, giant papillary conjunctivitis, vernal kerato conj…
- 細菌性結膜炎薬の世界市場（～2026年） Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis …